Financhill
Back

Arrowhead Pharmaceuticals 10K Form

Sell
46

ARWR
Arrowhead Pharmaceuticals

Last Price:
28.70
Seasonality Move:
12.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARWR News And Ratings

See the #1 stock for the next 7 days that we like better than ARWR

ARWR Financial Statistics

Sales & Book Value

Annual Sales: $240.74M
Cash Flow: $-186.5M
Price / Cash Flow: 0
Annual Sales: $1.49
Price / Book: 22.18

Profitability

EPS (TTM): -2.77000
Net Income (TTM): $-296.81M
Gross Margin: $0
Return on Equity: -87.08%
Return on Assets: -37.38%

Arrowhead Pharmaceuticals Earnings Forecast

Key Arrowhead Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 20 years for ARWR is 0.00%.
  • The Selling, General & Administrative Expenses for ARWR have been equal to 37.77% of Gross Profit Margin.
  • The Research & Development expenses have been 146.71% of Revenue.
  • The Interest Expense is -8.93% of Operating Income.
  • The Net Earning history of ARWR is -85.27% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 12 years.

Arrowhead Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ARWR
CUSIP: 04280A
Website: arrowheadpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.73
Quick Ratio: 3.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARWR Technical Analysis vs Fundamental Analysis

Sell
46
Arrowhead Pharmaceuticals (ARWR) is a Sell

Is Arrowhead Pharmaceuticals a Buy or a Sell?